Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
17.94T | 17.61T | 17.30T | 16.75T | 18.62T |
Gross Profit | ||||
12.93T | 12.74T | 15.05T | 14.52T | 15.95T |
EBIT | ||||
1.82T | 1.75T | 1.61T | 1.95T | 2.42T |
EBITDA | ||||
5.16T | 5.09T | 5.27T | 5.22T | 4.81T |
Net Income Common Stockholders | ||||
1.30T | 1.09T | 912.40B | 1.27T | 1.50T |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.35T | 1.75T | 2.12T | 1.39T | 2.95T |
Total Assets | ||||
30.52T | 30.12T | 31.31T | 30.91T | 47.91T |
Total Debt | ||||
6.67T | 10.66T | 11.08T | 10.37T | 12.16T |
Net Debt | ||||
4.32T | 9.20T | 9.20T | 9.50T | 10.79T |
Total Liabilities | ||||
18.64T | 17.89T | 19.15T | 18.58T | 23.51T |
Stockholders Equity | ||||
11.75T | 10.99T | 11.32T | 11.58T | 23.74T |
Cash Flow | Free Cash Flow | |||
0.00 | 1.87T | 2.11T | 1.72T | 2.13T |
Operating Cash Flow | ||||
0.00 | 4.95T | 5.16T | 5.03T | 5.82T |
Investing Cash Flow | ||||
0.00 | -3.35T | -2.81T | -3.49T | -4.25T |
Financing Cash Flow | ||||
0.00 | -2.02T | -1.35T | -2.05T | -1.46T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $192.30B | 17.96 | 10.54% | 4.14% | -0.08% | -24.48% | |
76 Outperform | $293.46B | 26.59 | 17.93% | 1.19% | 3.62% | 38.24% | |
74 Outperform | $57.45B | 10.34 | 38.11% | ― | 0.88% | 16.44% | |
73 Outperform | $184.17B | 10.55 | 18.27% | 6.14% | 0.61% | 50.39% | |
69 Neutral | $8.13B | 9.04 | 11.19% | 5.35% | -2.34% | 12.31% | |
64 Neutral | $6.22B | ― | -17.68% | ― | 32.25% | 20.56% | |
59 Neutral | $28.84B | 0.84 | -18.78% | 3.98% | 2.13% | -47.15% |